Trial Profile
A Prospective Clinical Trial of Improving the Treatment of Thoracic Esophageal Cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Apr 2021
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Nedaplatin (Primary) ; Cisplatin
- Indications Oesophageal cancer; Squamous cell cancer
- Focus Therapeutic Use
- 05 Apr 2021 Status changed from active, no longer recruiting to completed.
- 29 Oct 2019 Status changed from recruiting to active, no longer recruiting.
- 05 Jun 2018 Planned number of patients changed from 3138 to 122.